Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,448,458,890
-$1,573,120,742 QoQ
Shares Held
66,870,816
-7.0% QoQ
Ownership
5.39%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#3
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. GILD ranks #2 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,448,458,890 | 66,870,816 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,021,579,632 | 71,906,290 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,049,226,598 | 65,579,490 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,695,106,969 | 60,316,279 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,647,252,644 | 59,955,377 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,559,725,443 | 58,542,842 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,724,305,930 | 40,319,432 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,780,328,822 | 33,162,319 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,268,060,856 | 18,482,158 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,288,359,233 | 17,588,522 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,385,080,461 | 17,097,648 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,438,972,322 | 19,201,659 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,546,888,460 | 20,071,214 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,734,826,530 | 20,909,082 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,411,279,821 | 16,438,903 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $181,399,442 | 2,940,500 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $181,689,998 | 2,939,492 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $375,311,177 | 6,313,056 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $567,995,788 | 7,822,556 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $441,330,529 | 6,318,261 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $241,633,663 | 3,509,057 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $165,899,392 | 2,566,910 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $218,908,394 | 3,757,439 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $487,209,116 | 7,710,225 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $969,639,272 | 12,602,538 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $823,840,170 | 11,019,799 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||